<DOC>
	<DOCNO>NCT00623467</DOCNO>
	<brief_summary>This study involve use Magnetic Resonance Imaging ( MRI ) contrast agent call Gadavist . The purpose study look safety ( side effect ) efficacy ( well work ) Gadavist use take image brain spine . The result MRI compare result image take without Gadavist .</brief_summary>
	<brief_title>Safety Efficacy Gadobutrol 1.0 Molar ( Gadavist ) Patients Central Nervous System ( CNS ) Imaging</brief_title>
	<detailed_description>Issues safety address Adverse Events section .</detailed_description>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Central Nervous System Diseases</mesh_term>
	<criteria>Patients refer contrast enhance MRI CNS base symptom previous procedure . Patients acute renal insufficiency Patients severe renal disease Patients contraindication magnetic resonance imaging .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Central Nervous System Imaging</keyword>
	<keyword>Diagnostic Imaging</keyword>
</DOC>